Skip to main content
VNDA logo
VNDA
(NASDAQ)
Vanda Pharmaceuticals Inc.
$7.00-- (--)
Loading... - Market loading

Vanda Pharmaceuticals (VNDA) Stock Price & Financial Analysis

Vanda Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.76 - $7.00
52-Week High$9.94
52-Week Low$3.81
Open$6.84
Volume919.73K
Average Volume (3M)919.73K
Market Cap412.51M
Shares Outstanding58.93M
Price to Sales (P/S)1.93
Price to Book (P/B)1.27
EV/EBITDA-2.47
Revenue (TTM)216.10M
Net Income (TTM)-220.47M
Free Cash Flow (TTM)-110.44M
EPS (TTM)$-3.73
Profit Margin-102.02%
Operating Margin-69.95%
Return on Equity (ROE)-67.38%
Debt to Equity0.04
50-Day MA$7.70
200-Day MA$5.86
52-Week Change57.11%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Vanda Pharmaceuticals

What is the current stock price for VNDA?

As of the latest trading session, VNDA stock trades at $7.00. The 52-week range is $3.81–$9.94, with a day range of $6.76–$7.00.

What is the P/E ratio for VNDA?

The P/E ratio (Price-to-Earnings) for VNDA is shown in the Key Statistics section. This valuation metric helps compare Vanda Pharmaceuticals Inc. to industry peers.

Does VNDA pay dividends?

Vanda Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VNDA?

Based on 2 analysts, the consensus for VNDA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VNDA?

Vanda Pharmaceuticals's market capitalization is $412.5M, classifying it as a small-cap company. Vanda Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.